D20054;LITT for Spine Tumors
Starting soon · Not applicable
Conditions studied: Spinal Metastases
In brief
The objective of this clinical study is to evaluate the efficacy and safety of spinal laser interstitial therapy in the treatment of metastatic spinal tumors. The investigators hypothesize that rates of local tumor control are comparable between conventional open surgical techniques and spinal laser interstitial therapy.
Key facts
- Study ID
- NCT06548061
- Run by
- Dartmouth-Hitchcock Medical Center
- People needed
- 25
- Starts
- 2028-01-01
- Expected to finish
- 2031-06-30
- Last updated by the study team
- 2026-08-06
Who can join
Age: 19 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Histology confirmed spinal tumor involving the T2-T12 spine segments.
- Indication for spine stereotactic radiosurgery or palliative intervention.
- Normal neurologic exam at the time of presentation (Frankel grade E).
You may not qualify if…
- Contraindication to MRI
- ANY neurologic deficit
- Tumor spanning more than 3 consecutive vertebral segments
- Contraindication to general anesthesia
- Pregnancy
Where it is running
- Dartmouth Health — Lebanon, New Hampshire, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.